; for the Berlin Stroke Register and the Stroke Register of Northwest Germany Background and Purpose-Poststroke pneumonia is a potentially preventable complication after stroke associated with poor outcome. We developed and externally validated a prognostic score for predicting risk of pneumonia after ischemic stroke. Methods-The prognostic score was developed based on clinical data routinely collected after admission from the Berlin Stroke Register, Germany. The association of demographics, comorbidities, and clinical characteristics with poststroke pneumonia was investigated using multivariable logistic regression analyses. Independent predictors of poststroke pneumonia were translated into a point scoring system based on the corresponding regression coefficients. The predictive properties of the developed prognostic score were externally validated using an independent data set from the Stroke Register Northwest-Germany. Results-Between 2007 and 2009, 15 335 patients with ischemic stroke were registered within the Berlin Stroke Register.
and 2 university hospitals (see the online-only Data Supplement) in the city of Berlin. The hospitals of the BSR serve for a source population of 3.4 million inhabitants, in which an estimated number of approximately 10 000 patients have a first ever or recurrent stroke per year based on estimates from epidemiological studies in Germany. 10 All BSR hospitals treat patients with stroke independent of age, sex, comorbidities, stroke etiology, and severity of stroke applying an interdisciplinary approach directed by neurologists. Patients with dysphagia usually receive early nasogastric feeding initially and, in case of persistent dysphagia, are provided with a percutaneous endoscopic gastrostomy tube. Patients requiring mechanical ventilation are usually transferred to an intensive care unit. Data from consecutively admitted patients with stroke were collected prospectively by treating physicians as part of a regional program for quality assurance. Sociodemographics, neurological deficits, comorbidities and stroke severity (National Institutes of Health Stroke Scale [NIHSS]) on admission, complications, processes, and outcomes during hospitalization were documented. All documenting physicians received standardized training and a detailed manual guided the data collection. The BSR is part of the German Stroke Registers Study Group (ADSR), a network of regional hospitalbased stroke registers for quality assurance in Germany. Within the ADSR, data collection methods and data definitions are standardized. 11 
Validation Cohort
The derived estimates were externally validated in the Stroke Register North-West Germany (NWSR). 12 The NWSR (http://campus. uni-muenster.de/qsnwd.html) includes 148 acute care hospitals and is also member of the ADSR. Thus, identical data definitions and data collection methods were used.
Data Definitions
The following data definitions were used in the current analyses: age (categorized a priori as Ͻ65 years, 65-74 years, 75-84 years, Ն85 years); sex; comorbidities including: hypertension (any treatment and/or patient's self-report); diabetes mellitus (any treatment and/or patient's self-report); previous stroke (neurological deficit Ͼ24 hours before the current event); atrial fibrillation (patient's selfreport and/or documented by standard electrocardiogram or Holter monitor); stroke severity on admission assessed by the NIHSS and categorized based on previously defined cut points 13 into: mild (NIHSS Ͻ5), moderately severe (NIHSS 4 -15), severe/very severe (NIHSS Ն16) impairment; and clinical symptoms on admission (evidence for any type of dysphagia, eg, documented by a standardized dysphagia screening test). With the exception of the history for atrial fibrillation, all information was collected and documented directly after admission. Pneumonia during hospitalization was defined by the treating physician based on clinical symptoms and/or suggestive clinical examination and/or radiological findings and/or pathogen detection of pulmonary infection. Only hospital-acquired pneumonia was documented; pneumonia before stroke was not considered. Stroke was defined according to World Health Organization criteria 14 and classified based on results from first brain scan into ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage. For the present analyses only patients with ischemic stroke were considered.
Statistical Analyses
For developing and reporting prognostic models, we followed current guidance on this topic. 15 Crude and adjusted ORs were calculated using univariate and multivariable logistic regression models, respectively.
Development of the Basic Clinical Score
The basic clinical score was developed in the derivation cohort. In a first step we defined variables potentially predictive for the risk of pneumonia on which information could be easily collected on admission including: demographics (age, sex), comorbidities (atrial fibrillation, diabetes, hypertension, previous stroke), symptoms of dysphagia, and stroke severity (assessed by the NIHSS). Variables associated with poststroke pneumonia at a significance level of 0.1 in univariate analysis were included in a multivariable logistic regression model using a backward elimination procedure. Due to prior reports that male sex is a significant predictor for poststroke pneumonia, 16 we a priori decided to include sex in the list of our possible predictors. We defined an OR in multivariable analyses of Ն1.25 to be clinically meaningful for prediction of poststroke pneumonia. For all variables reaching this OR in the multivariable model, we attributed between 1 and 5 points based on the derived point estimates. The original 4 categories for the variable age were reduced to 2 categories (Ͻ75 years and Ն75 years) based on the similarity of the point estimates of the younger and older age groups. For the definition of the final prognostic score, the sum of all points was chosen. The risk of pneumonia during hospitalization was stratified by the prognostic score. The derived prognostic score discrimination abilities were assessed by the C-statistics calculating sensitivity and specificity of prediction at each cutoff point of the score. The C-statistics represent the area under the receiver operating characteristic curve and a C-statistic of 0.5 indicates no ability, whereas a C-statistic of 1.0 indicates perfect ability to discriminate between patients with or without pneumonia during hospitalization. In addition, we assessed the calibration of the prognostic score. Because we consider a logistic regression model with only one categorical predictor variable (10- 
External Validation of the Basic Clinical Score
The estimates from the derivation cohort were externally validated using the data set of the NWSR. Prediction, discrimination, and calibration of the derived prognostic score were investigated. The validation set was used only to reproduce the observed properties in terms of predicting risk of pneumonia.
For statistical analyses, patients with missing values on a specific variable were excluded from analysis. The number of patients with missing values ranged in the BSR from 0% for age to 10.5% for NIHSS and in the NWSR from 0.1% for age to 12.1% for NIHSS. All tests were 2-tailed and statistical significance was determined at an ␣ level of 0.05. Statistical analyses were performed with the PASW 18 software package.
Ethics
The study was approved by the ethics committee of the Charité-Universitaetsmedizin Berlin (EA1/216/09). Participation of hospitals in programs for quality assurance of acute clinical care is mandatory in Germany. Because the identity of individual patients is completely anonymous in the respective stroke registers, no specific informed consent was provided by the patients or relatives. The investigators performing the statistical analysis were blinded to hospital identities. Hospital identities were only known to the coordinating offices of the respective registers.
Results

Patient's Demographic and Clinical Characteristics
Patients with stroke admitted to one of the 14 BSR hospitals between January 2007 and December 2009 were considered in the present data analyses. Overall 15 335 patients with ischemic stroke were included. Mean age of patients was 71.2 years (SD 13.1); 50.6 were male. Demographic and clinical characteristics of patients are shown in Table 1 .
The observed rate of pneumonia in hospital was 7.2%. The association between clinical variables on admission and incidence of pneumonia during hospitalization in univariate analysis is shown in Table 2 . The following variables were revealed to be significant at a probability value of 0.1 in univariate analysis and were therefore included in the multivariable analysis: age Ն75 years, atrial fibrillation, diabetes mellitus, hypertension, previous stroke, stroke severity as measured by NIHSS, and symptoms of dysphagia. A multivariable logistic regression model with stepwise backward variable selection showed that the following variables were significantly associated with poststroke pneumonia and reached the a priori defined OR of 1.25 indicating clinical significance (Table 3) : age Ն75 years, male sex, atrial fibrillation, stroke severity as measured by NIHSS, and symptoms of dysphagia.
Including length of stay in the final multivariable model as sensitivity analysis did not change the point estimates of any of the variables substantially (data not shown). Furthermore, excluding patients with mechanical ventilation during hospitalization from our analysis did not change any of the observed association substantially (data not shown).
Development of the Basic Clinical Score
Based on the coefficients from the multivariable logistic regression model, the independent predictors for poststroke pneumonia were translated into a point scoring system. One point was assigned to independent predictors with an adjusted OR between 1.25 and Ͻ2.0, 2 points were assigned to predictors with an OR between 2.0 and Ͻ4.0, and 3 points for an OR between 4.0 and Ͻ6.0. To avoid the overemphasis of stroke severity, an NIHSS score of Ն16 received 5 points instead of 7 points. Thus, the A 2 DS 2 score, a 10-point score, was derived (Table 4 ). The proportion of poststroke pneumonia in the derivation cohort varied between 0.3% in patients with a score of 0 point to 39.4% in patients with a score of 10 points (online-only Data Supplement Figure I ).
External Validation
For external validation, 45 085 patients with ischemic stroke admitted consecutively to one of the 140 hospitals within the NWSR between January 2009 and December 2009 were considered. Demographic and clinical characteristics of patients in the validation data set were comparable to the derivation data set ( Table 1 ). All predictors for poststroke pneumonia in the derivation cohort showed a significant association with poststroke pneumonia in the validation cohort in univariate and multivariable analysis (Tables 2 and  3 ). The cut point specific sensitivity and specificity of the A 2 DS 2 score in the derivation and validation cohort are shown in online-only Data Supplement Figure II . The measures for indicating discrimination and calibration of the derivation and validation cohort are shown in Table 5 .
Discussion
Our study aimed to develop a simple, valid, and clinically useful tool for predicting risk of pneumonia in patients with acute ischemic stroke. For this purpose, the A 2 DS 2 score was developed based on routinely collected data available directly after hospital admission. We used data of 2 well-established stroke registers in Germany that prospectively collect clinical data of patients with acute stroke. We could demonstrate good discrimination and calibration abilities of the A 2 DS 2 score in the derivation data set and validated these observations externally within an independent data set using identical data definitions and data collection methods. Important measures to assess the accuracy of a prediction model are calibration (agreement between observed probabilities and predicted probabilities) and discrimination (ability to distinguish subjects with different outcomes). 15 Furthermore, prediction models need to prove their validity in new patients that preferably are fully independent from the derivation cohort (external validation). 17 However, even good calibration and discrimination abilities may not be sufficient for a prediction model to be clinical useful. Clinical usefulness includes areas such as additional information required for medical decisionmaking, cost-effectiveness, and practicability in terms of easily collecting the required information. Previous studies have identified several factors being independently associated with poststroke pneumonia in acute stroke. Consistent associations were shown for older age, stroke severity, dysphagia, and impaired level of consciousness. 18 -20 Some of these findings have been translated into scoring systems aiming at risk stratification for poststroke pneumonia. However, these scoring systems are not widely used in clinical practice yet. Chumbler et al 7 presented a 3-level scoring system for predicting pneumonia in acute stroke that included medical history of pneumonia, symptoms of dysphagia, increasing NIHSS, being found down at the time of symptom onset, and age Ͼ70 years and showed acceptable C-statistics; however, the study based on retrospective data collection and was not externally validated. The pneumonia score of Kwon et al 9 including NIHSS, age, sex, mechanical ventilation, and dysphagia was derived from a small cohort and was not validated. Sellars et al 8 presented key characteristics for the prediction of poststroke pneumonia, among them older age, dysarthria or no speech due to aphasia, a modified Rankin Scale score Ͼ or ϭ 4, a low Abbreviated Mental Test score and a failed staged water swallowing test. Although informative, the latter 2 predictors might be difficult to collect in a standardized way in clinical routine.
To the best of our knowledge, this is the first study providing a simple scoring system for the prediction of poststroke pneumonia based on routinely collected data on admission that were externally validated within an independent data set and that showed excellent discrimination and calibration abilities. Our findings underline the multifactorial pathogenesis of poststroke pneumonia and deliver easily accessible clinical characteristics as strong predictors for risk stratification. As shown in previous studies, older age was independently associated with poststroke pneumonia. This might be due to the fact that advanced age per se is associated with comorbid medical conditions and impairment of swallowing and the cough reflex. 21 Male sex was a further predictor for poststroke pneumonia. This finding is in line with the study by Reid et al 22 showing that male patients are at higher risk for stroke-associated pneumonia even when adjusted for potential confounders. Although not documented in our cohorts, the higher rate of poststroke pneumonia for male sex might be attributable to the higher prevalence of smoking and pre-existing pulmonary disease among men. 23, 24 However, other studies did not find such association and the influence of sex differences on poststroke infections needs further investigation. Stroke severity as measured by the NIHSS is a well-known factor influencing probability of poststroke pneumonia. 19 A higher NIHSS score is associated with a deteriorated level of consciousness and decreased bulbar reflexes making aspiration more likely. 18 Correspondingly, dysphagia was verified as a predictor of poststroke pneumonia in previous studies. 25 Patients with dysphagia are prone for aspiration, which, in turn, is a strong risk factor for pneumonia. The association of atrial fibrillation with poststroke infections has been shown in only one study. 26 Atrial fibrillation is a proxy for cardioembolic stroke, which is associated with cortical infarctions and higher stroke severity. 27 Thus, residual confounding for stroke severity cannot be excluded, although this finding was still present even after adjustment for NIHSS. Koennecke et al 6 recently showed that up to one third of all in-hospital deaths after Day 7 are independently attributed to early medical or neurological complications with pneumonia being the most important potentially modifiable complication. Current guidelines of stroke treatment recommend early antibiotic treatment in case of suspected infection. 28 However, evidence-based data on guiding prevention and early management of poststroke infections are lacking. The A 2 DS 2 score might serve as a useful tool to identify patients at high risk of poststroke pneumonia. For example, an A 2 DS 2 score of Ն4 predicts with a sensitivity of 91% and a specificity of 57% the occurrence of poststroke pneumonia; an A 2 DS 2 score of Ն5 yields a sensitivity of 83% and a specificity of 72% (online-only Data Supplement Table VI ; online-only Data Supplement Figure II) . The cut point specific positive and negative predictive values are shown in online-only Data Supplement Table VI . These cutoff values might be useful for the identification of high-risk patients in need of more intense monitoring and/or the initiation of prophylactic antibiotic treatment. However, before finding implementation in clinical practice, the predictive properties of the A 2 DS 2 score must be assessed in prospective clinical studies. We are currently score proves its external validity within this setting, large prospective randomized clinical trials on preventive therapies for poststroke pneumonia could base their patient selection on the A 2 DS 2 score. The study has strengths and limitations. The large sample size of both the derivation and validation cohorts ensures precision and robustness of the main estimates. The inclusion of information easily accessible on admission might increase the practicability of the A 2 DS 2 . However, due to the design of the study, the level of detail of collected information is limited. For example, our data do not provide information on clinical symptoms, laboratory tests, and/or chest radiographs that lead to the diagnosis of pneumonia. Moreover, although it is explicitly stated in the manual guiding data collection that only hospital-acquired pneumonia shall be documented and pneumonia before stroke must not be considered, we cannot entirely assure that in each individual case of pneumonia this recommendation has been followed. Furthermore, the diagnosis of pneumonia was based on clinical judgment of treating physicians only and no standardized criteria such as the Centers for Disease Control and Prevention criteria for the diagnosis of "clinically defined pneumonia" were applied. However, this might reflect clinical routine and recent studies showed that poor interrater reliability also applies to validated standardized criteria. 29, 30 Moreover, our reported rate of pneumonia is comparable to that of other large studies and a meta-analysis on poststroke infections, 31, 32 making large quantities of misdiagnoses of poststroke pneumonia unlikely.
In addition, the time course of pneumonia onset is unclear. In our data set, diagnosis of pneumonia is correlated with a longer length of stay but including length of stay in the final multivariable model as sensitivity analysis did not change the point estimates of any of the variables substantially. Because we only have information on new-onset pneumonia during the time of hospitalization without documentation of the exact days, our data allow no conclusion as to whether patients with a longer length of stay per se are more likely to develop pneumonia or if diagnosis of pneumonia leads to a longer hospitalization as shown in previous studies. 33 We therefore abstained from including length of stay in our analyses.
The limited information on time course of pneumonia also does not allow for a safe interpretation of causality between mechanical ventilation and pneumonia. We therefore abstained from including mechanical ventilation in our prognostic score for mainly 2 reasons. First, the aim of our study was to develop a prognostic score for the prediction of poststroke pneumonia on the first day after stroke onset. Ventilator-associated pneumonia is its own entity and assumed to be caused by mechanical ventilation itself and other risk factors that substantially differ from those identified for the development of poststroke pneumonia. 34 Second, our data do not allow for firm conclusions concerning the temporal sequence of events. Several studies indicate that pneumonia precedes mechanical ventilation, 35 thus making pneumonia a possible "risk factor" for mechanical ventilation and not necessarily vice versa. Also, restricting our analysis to patients not ventilated did not change any of the observed association substantially.
Another limitation of this study is the lack of standardized criteria for the diagnosis of dysphagia. The German Society for Neurology (DGN) recommends that stroke units follow a semi-intensive stroke unit concept for specialized treatment of patients with stroke. 36 This concept contains the European Stroke Organization-recommended minimum requirements that require one to perform routine screening for dysphagia for all admitted patients within 24 hours after admission and to withhold oral feeding until the patient has demonstrated intact swallowing with small amounts of water and intact coughing on command. 37 Yet no instrumental or standardized bedside screening test for the detection and gradation of dysphagia was performed. However, dysphagia has been shown to be an important but not sufficient factor for the development of poststroke pneumonia in prior studies. 38 The A 2 DS 2 score introduces other independent clinical variables as strong predictors for poststroke pneumonia, yet a comparison of the predictive properties of the A 2 DS 2 and validated bedside screening tests for dysphagia 39 in future studies would be highly informative.
Furthermore, stroke localization (posterior/anterior circulation) was not documented. Posterior circulation strokes are more likely to lead to dysphagia and a reduced level of consciousness increasing the risk of poststroke pneumonia.
Conclusions
The A 2 DS 2 score might be a valid tool for the prediction of poststroke pneumonia based on routinely collected data. If the A 2 DS 2 proves prospective validity, it might be useful for the guidance of increased monitoring and prophylactic treatment in identified high-risk patients for poststroke pneumonia in clinical routine. 
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